nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—pancreatic cancer—kidney cancer	0.376	1	CtDrD
Tamoxifen—CYP1A1—kidney cancer	0.0802	0.653	CbGaD
Tamoxifen—ABCB1—kidney cancer	0.0426	0.347	CbGaD
Tamoxifen—DHCR7—Doxorubicin—kidney cancer	0.0325	0.0991	CbGbCtD
Tamoxifen—CES1—Capecitabine—kidney cancer	0.0266	0.081	CbGbCtD
Tamoxifen—CYP1B1—Erlotinib—kidney cancer	0.0104	0.0318	CbGbCtD
Tamoxifen—CYP3A7—Temsirolimus—kidney cancer	0.00978	0.0298	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.00978	0.0298	CbGbCtD
Tamoxifen—CYP1B1—Paclitaxel—kidney cancer	0.00956	0.0291	CbGbCtD
Tamoxifen—ABCB11—Paclitaxel—kidney cancer	0.00956	0.0291	CbGbCtD
Tamoxifen—ABCB11—Vinblastine—kidney cancer	0.00839	0.0256	CbGbCtD
Tamoxifen—ABCB11—Vincristine—kidney cancer	0.00825	0.0251	CbGbCtD
Tamoxifen—CYP19A1—Paclitaxel—kidney cancer	0.00775	0.0236	CbGbCtD
Tamoxifen—CYP3A5—Temsirolimus—kidney cancer	0.00734	0.0224	CbGbCtD
Tamoxifen—ABCG2—Pazopanib—kidney cancer	0.00696	0.0212	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—kidney cancer	0.00636	0.0194	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—kidney cancer	0.00515	0.0157	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—kidney cancer	0.00515	0.0157	CbGbCtD
Tamoxifen—ABCC2—Paclitaxel—kidney cancer	0.00503	0.0153	CbGbCtD
Tamoxifen—ABCG2—Erlotinib—kidney cancer	0.00497	0.0151	CbGbCtD
Tamoxifen—ABCB1—Temsirolimus—kidney cancer	0.00478	0.0146	CbGbCtD
Tamoxifen—CYP1A1—Erlotinib—kidney cancer	0.00458	0.014	CbGbCtD
Tamoxifen—ABCG2—Paclitaxel—kidney cancer	0.00455	0.0138	CbGbCtD
Tamoxifen—CYP2D6—Temsirolimus—kidney cancer	0.0045	0.0137	CbGbCtD
Tamoxifen—ABCC2—Sorafenib—kidney cancer	0.00447	0.0136	CbGbCtD
Tamoxifen—ABCC2—Vinblastine—kidney cancer	0.00441	0.0134	CbGbCtD
Tamoxifen—ABCC2—Vincristine—kidney cancer	0.00434	0.0132	CbGbCtD
Tamoxifen—CYP3A4—Everolimus—kidney cancer	0.00424	0.0129	CbGbCtD
Tamoxifen—ABCG2—Sorafenib—kidney cancer	0.00404	0.0123	CbGbCtD
Tamoxifen—ABCG2—Vincristine—kidney cancer	0.00392	0.0119	CbGbCtD
Tamoxifen—CYP2C8—Pazopanib—kidney cancer	0.00371	0.0113	CbGbCtD
Tamoxifen—ABCC2—Sunitinib—kidney cancer	0.00362	0.011	CbGbCtD
Tamoxifen—CYP3A7—Paclitaxel—kidney cancer	0.00336	0.0102	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00336	0.0102	CbGbCtD
Tamoxifen—ABCG2—Sunitinib—kidney cancer	0.00327	0.00997	CbGbCtD
Tamoxifen—CYP3A7—Sorafenib—kidney cancer	0.00298	0.00909	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00298	0.00909	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—kidney cancer	0.00289	0.00882	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00289	0.00882	CbGbCtD
Tamoxifen—CYP1A2—Pazopanib—kidney cancer	0.00287	0.00874	CbGbCtD
Tamoxifen—CYP3A4—Temsirolimus—kidney cancer	0.00286	0.00872	CbGbCtD
Tamoxifen—CYP2B6—Sorafenib—kidney cancer	0.00284	0.00865	CbGbCtD
Tamoxifen—CYP3A5—Erlotinib—kidney cancer	0.00275	0.00838	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—kidney cancer	0.00271	0.00826	CbGbCtD
Tamoxifen—CYP2C9—Capecitabine—kidney cancer	0.0027	0.00822	CbGbCtD
Tamoxifen—CYP2C8—Erlotinib—kidney cancer	0.00265	0.00806	CbGbCtD
Tamoxifen—CYP3A5—Paclitaxel—kidney cancer	0.00252	0.00767	CbGbCtD
Tamoxifen—ABCB1—Pazopanib—kidney cancer	0.00251	0.00765	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—kidney cancer	0.00245	0.00746	CbGbCtD
Tamoxifen—CYP2C8—Paclitaxel—kidney cancer	0.00242	0.00738	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00242	0.00736	CbGbCtD
Tamoxifen—CYP3A7—Sunitinib—kidney cancer	0.00242	0.00736	CbGbCtD
Tamoxifen—CYP2D6—Pazopanib—kidney cancer	0.00236	0.0072	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—kidney cancer	0.0023	0.00699	CbGbCtD
Tamoxifen—CYP3A5—Sorafenib—kidney cancer	0.00224	0.00682	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—kidney cancer	0.00217	0.00662	CbGbCtD
Tamoxifen—CYP2C8—Sorafenib—kidney cancer	0.00215	0.00655	CbGbCtD
Tamoxifen—CYP1A2—Erlotinib—kidney cancer	0.00205	0.00624	CbGbCtD
Tamoxifen—FMO3—urine—kidney cancer	0.00204	0.0771	CbGeAlD
Tamoxifen—ABCB1—Gemcitabine—kidney cancer	0.00181	0.00553	CbGbCtD
Tamoxifen—CYP3A5—Sunitinib—kidney cancer	0.00181	0.00552	CbGbCtD
Tamoxifen—CYP2C19—Sorafenib—kidney cancer	0.0018	0.0055	CbGbCtD
Tamoxifen—ABCB1—Erlotinib—kidney cancer	0.00179	0.00546	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—kidney cancer	0.00172	0.00525	CbGbCtD
Tamoxifen—CYP2C9—Paclitaxel—kidney cancer	0.00169	0.00515	CbGbCtD
Tamoxifen—CYP2D6—Erlotinib—kidney cancer	0.00169	0.00514	CbGbCtD
Tamoxifen—CYP1A2—Sorafenib—kidney cancer	0.00166	0.00507	CbGbCtD
Tamoxifen—ABCB1—Paclitaxel—kidney cancer	0.00164	0.00499	CbGbCtD
Tamoxifen—CYP3A4—Pazopanib—kidney cancer	0.0015	0.00458	CbGbCtD
Tamoxifen—CYP2C9—Sorafenib—kidney cancer	0.0015	0.00457	CbGbCtD
Tamoxifen—ABCB1—Sorafenib—kidney cancer	0.00146	0.00444	CbGbCtD
Tamoxifen—ABCB1—Vinblastine—kidney cancer	0.00144	0.00438	CbGbCtD
Tamoxifen—ABCB1—Vincristine—kidney cancer	0.00141	0.00431	CbGbCtD
Tamoxifen—CYP2D6—Sorafenib—kidney cancer	0.00137	0.00418	CbGbCtD
Tamoxifen—CYP2D6—Vinblastine—kidney cancer	0.00135	0.00413	CbGbCtD
Tamoxifen—ABCB1—Sunitinib—kidney cancer	0.00118	0.00359	CbGbCtD
Tamoxifen—CYP3A4—Erlotinib—kidney cancer	0.00107	0.00327	CbGbCtD
Tamoxifen—CYP3A4—Paclitaxel—kidney cancer	0.000982	0.00299	CbGbCtD
Tamoxifen—CYP2C19—urine—kidney cancer	0.000903	0.0341	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—kidney cancer	0.000883	0.00269	CbGbCtD
Tamoxifen—CYP3A4—Sorafenib—kidney cancer	0.000872	0.00266	CbGbCtD
Tamoxifen—CYP3A4—Vinblastine—kidney cancer	0.000861	0.00262	CbGbCtD
Tamoxifen—CYP3A4—Vincristine—kidney cancer	0.000847	0.00258	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—kidney cancer	0.000832	0.00254	CbGbCtD
Tamoxifen—SULT1A1—renal system—kidney cancer	0.000814	0.0307	CbGeAlD
Tamoxifen—SULT1A1—kidney—kidney cancer	0.000787	0.0297	CbGeAlD
Tamoxifen—CYP1A2—urine—kidney cancer	0.000738	0.0278	CbGeAlD
Tamoxifen—UGT1A4—renal system—kidney cancer	0.00071	0.0268	CbGeAlD
Tamoxifen—CYP3A4—Sunitinib—kidney cancer	0.000707	0.00215	CbGbCtD
Tamoxifen—CYP2C9—urine—kidney cancer	0.0007	0.0264	CbGeAlD
Tamoxifen—UGT1A4—kidney—kidney cancer	0.000686	0.0259	CbGeAlD
Tamoxifen—CYP2E1—urine—kidney cancer	0.000664	0.025	CbGeAlD
Tamoxifen—DHCR7—nephron tubule—kidney cancer	0.000637	0.024	CbGeAlD
Tamoxifen—FMO1—nephron tubule—kidney cancer	0.000637	0.024	CbGeAlD
Tamoxifen—ESRRA—nephron tubule—kidney cancer	0.000627	0.0236	CbGeAlD
Tamoxifen—FMO1—renal system—kidney cancer	0.000579	0.0218	CbGeAlD
Tamoxifen—ESRRA—renal system—kidney cancer	0.00057	0.0215	CbGeAlD
Tamoxifen—FMO1—kidney—kidney cancer	0.000559	0.0211	CbGeAlD
Tamoxifen—ESRRA—kidney—kidney cancer	0.000551	0.0208	CbGeAlD
Tamoxifen—DHCR7—cortex of kidney—kidney cancer	0.000545	0.0206	CbGeAlD
Tamoxifen—FMO1—cortex of kidney—kidney cancer	0.000545	0.0206	CbGeAlD
Tamoxifen—ESRRA—cortex of kidney—kidney cancer	0.000536	0.0202	CbGeAlD
Tamoxifen—CYP3A4—urine—kidney cancer	0.000534	0.0201	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—kidney cancer	0.000529	0.00161	CbGbCtD
Tamoxifen—CYP2D6—urine—kidney cancer	0.000526	0.0198	CbGeAlD
Tamoxifen—DHCR7—gonad—kidney cancer	0.000519	0.0196	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—kidney cancer	0.000518	0.0196	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—kidney cancer	0.00051	0.0192	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000463	0.0175	CbGeAlD
Tamoxifen—EBP—Sirolimus—Everolimus—kidney cancer	0.000412	0.306	CbGdCrCtD
Tamoxifen—EBP—Temsirolimus—Everolimus—kidney cancer	0.000412	0.306	CbGdCrCtD
Tamoxifen—EBP—Sirolimus—Temsirolimus—kidney cancer	0.000412	0.306	CbGdCrCtD
Tamoxifen—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000396	0.0149	CbGeAlD
Tamoxifen—Dimetacrine—ACHE—kidney cancer	0.000368	0.305	CrCbGaD
Tamoxifen—ESR2—renal system—kidney cancer	0.000342	0.0129	CbGeAlD
Tamoxifen—ESR2—kidney—kidney cancer	0.000331	0.0125	CbGeAlD
Tamoxifen—ESR2—gonad—kidney cancer	0.000307	0.0116	CbGeAlD
Tamoxifen—Loperamide—POMC—kidney cancer	0.000298	0.248	CrCbGaD
Tamoxifen—SIGMAR1—nephron tubule—kidney cancer	0.000291	0.011	CbGeAlD
Tamoxifen—ABCC2—nephron tubule—kidney cancer	0.000283	0.0107	CbGeAlD
Tamoxifen—CYP1B1—nephron tubule—kidney cancer	0.000277	0.0105	CbGeAlD
Tamoxifen—ABCC2—renal system—kidney cancer	0.000257	0.0097	CbGeAlD
Tamoxifen—CYP1B1—renal system—kidney cancer	0.000252	0.0095	CbGeAlD
Tamoxifen—SIGMAR1—cortex of kidney—kidney cancer	0.000249	0.00941	CbGeAlD
Tamoxifen—ABCC2—kidney—kidney cancer	0.000249	0.00938	CbGeAlD
Tamoxifen—CYP1B1—kidney—kidney cancer	0.000244	0.00919	CbGeAlD
Tamoxifen—ABCC2—cortex of kidney—kidney cancer	0.000242	0.00914	CbGeAlD
Tamoxifen—CYP19A1—gonad—kidney cancer	0.000242	0.00912	CbGeAlD
Tamoxifen—SIGMAR1—cardiac atrium—kidney cancer	0.000237	0.00895	CbGeAlD
Tamoxifen—CYP1B1—cortex of kidney—kidney cancer	0.000237	0.00895	CbGeAlD
Tamoxifen—ESR1—renal system—kidney cancer	0.000234	0.00883	CbGeAlD
Tamoxifen—ESR1—kidney—kidney cancer	0.000226	0.00854	CbGeAlD
Tamoxifen—CYP1B1—gonad—kidney cancer	0.000226	0.00852	CbGeAlD
Tamoxifen—ESR1—gonad—kidney cancer	0.00021	0.00792	CbGeAlD
Tamoxifen—ABCG2—nephron tubule—kidney cancer	0.000206	0.00778	CbGeAlD
Tamoxifen—CYP2C8—renal system—kidney cancer	0.000193	0.00728	CbGeAlD
Tamoxifen—CYP3A5—nephron tubule—kidney cancer	0.000192	0.00723	CbGeAlD
Tamoxifen—CYP2B6—nephron tubule—kidney cancer	0.00019	0.00718	CbGeAlD
Tamoxifen—CYP2C8—kidney—kidney cancer	0.000186	0.00704	CbGeAlD
Tamoxifen—CYP1A2—renal system—kidney cancer	0.000181	0.00681	CbGeAlD
Tamoxifen—CYP2E1—nephron tubule—kidney cancer	0.000179	0.00674	CbGeAlD
Tamoxifen—CYP1A1—renal system—kidney cancer	0.000178	0.00672	CbGeAlD
Tamoxifen—CYP3A5—renal system—kidney cancer	0.000174	0.00657	CbGeAlD
Tamoxifen—CYP2B6—renal system—kidney cancer	0.000173	0.00653	CbGeAlD
Tamoxifen—CYP1A1—kidney—kidney cancer	0.000172	0.00649	CbGeAlD
Tamoxifen—CYP3A5—kidney—kidney cancer	0.000168	0.00635	CbGeAlD
Tamoxifen—CYP2B6—kidney—kidney cancer	0.000167	0.00631	CbGeAlD
Tamoxifen—CYP3A5—cortex of kidney—kidney cancer	0.000164	0.00618	CbGeAlD
Tamoxifen—CYP2E1—renal system—kidney cancer	0.000162	0.00613	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—kidney cancer	0.000159	0.00602	CbGeAlD
Tamoxifen—CYP2E1—kidney—kidney cancer	0.000157	0.00592	CbGeAlD
Tamoxifen—CYP2B6—gonad—kidney cancer	0.000155	0.00585	CbGeAlD
Tamoxifen—CYP2E1—cortex of kidney—kidney cancer	0.000153	0.00577	CbGeAlD
Tamoxifen—CYP3A4—renal system—kidney cancer	0.000131	0.00493	CbGeAlD
Tamoxifen—CYP2D6—renal system—kidney cancer	0.000129	0.00485	CbGeAlD
Tamoxifen—CYP3A4—kidney—kidney cancer	0.000126	0.00477	CbGeAlD
Tamoxifen—CYP2D6—kidney—kidney cancer	0.000124	0.00469	CbGeAlD
Tamoxifen—Toremifene—CYP1A1—kidney cancer	0.00012	0.0998	CrCbGaD
Tamoxifen—EBP—Azacitidine—Gemcitabine—kidney cancer	0.000111	0.0823	CbGdCrCtD
Tamoxifen—Clomifene—CYP1A1—kidney cancer	0.000104	0.0863	CrCbGaD
Tamoxifen—ABCB1—nephron tubule—kidney cancer	0.000102	0.00384	CbGeAlD
Tamoxifen—ABCB1—renal system—kidney cancer	9.25e-05	0.00349	CbGeAlD
Tamoxifen—ABCB1—kidney—kidney cancer	8.94e-05	0.00337	CbGeAlD
Tamoxifen—ABCB1—cortex of kidney—kidney cancer	8.71e-05	0.00329	CbGeAlD
Tamoxifen—ABCB1—gonad—kidney cancer	8.29e-05	0.00313	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCB1—kidney cancer	8.06e-05	0.0669	CrCbGaD
Tamoxifen—Toremifene—ABCB1—kidney cancer	6.39e-05	0.053	CrCbGaD
Tamoxifen—Clomifene—ABCB1—kidney cancer	5.52e-05	0.0458	CrCbGaD
Tamoxifen—Diphenhydramine—PTGS1—kidney cancer	5.39e-05	0.0448	CrCbGaD
Tamoxifen—Diarrhoea—Erlotinib—kidney cancer	3.59e-05	0.000374	CcSEcCtD
Tamoxifen—Thrombocytopenia—Gemcitabine—kidney cancer	3.57e-05	0.000372	CcSEcCtD
Tamoxifen—Loperamide—ABCB1—kidney cancer	3.55e-05	0.0295	CrCbGaD
Tamoxifen—Haemoglobin—Capecitabine—kidney cancer	3.54e-05	0.000369	CcSEcCtD
Tamoxifen—Hepatitis—Capecitabine—kidney cancer	3.53e-05	0.000368	CcSEcCtD
Tamoxifen—Haemorrhage—Capecitabine—kidney cancer	3.53e-05	0.000368	CcSEcCtD
Tamoxifen—Hyperhidrosis—Gemcitabine—kidney cancer	3.53e-05	0.000367	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—kidney cancer	3.52e-05	0.000367	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—kidney cancer	3.51e-05	0.000366	CcSEcCtD
Tamoxifen—Hypoaesthesia—Capecitabine—kidney cancer	3.51e-05	0.000366	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Vincristine—kidney cancer	3.5e-05	0.000365	CcSEcCtD
Tamoxifen—Pharyngitis—Capecitabine—kidney cancer	3.5e-05	0.000365	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—kidney cancer	3.48e-05	0.000363	CcSEcCtD
Tamoxifen—Hypersensitivity—Sorafenib—kidney cancer	3.48e-05	0.000363	CcSEcCtD
Tamoxifen—Insomnia—Vincristine—kidney cancer	3.48e-05	0.000362	CcSEcCtD
Tamoxifen—Anorexia—Gemcitabine—kidney cancer	3.48e-05	0.000362	CcSEcCtD
Tamoxifen—Oedema peripheral—Capecitabine—kidney cancer	3.47e-05	0.000362	CcSEcCtD
Tamoxifen—Vomiting—Vinblastine—kidney cancer	3.47e-05	0.000362	CcSEcCtD
Tamoxifen—Dizziness—Erlotinib—kidney cancer	3.47e-05	0.000362	CcSEcCtD
Tamoxifen—Vomiting—Everolimus—kidney cancer	3.46e-05	0.000361	CcSEcCtD
Tamoxifen—Anaemia—Paclitaxel—kidney cancer	3.46e-05	0.00036	CcSEcCtD
Tamoxifen—Paraesthesia—Vincristine—kidney cancer	3.45e-05	0.00036	CcSEcCtD
Tamoxifen—Dermatitis bullous—Doxorubicin—kidney cancer	3.44e-05	0.000358	CcSEcCtD
Tamoxifen—Rash—Everolimus—kidney cancer	3.43e-05	0.000358	CcSEcCtD
Tamoxifen—Dermatitis—Everolimus—kidney cancer	3.43e-05	0.000357	CcSEcCtD
Tamoxifen—Headache—Vinblastine—kidney cancer	3.42e-05	0.000357	CcSEcCtD
Tamoxifen—Angioedema—Paclitaxel—kidney cancer	3.42e-05	0.000356	CcSEcCtD
Tamoxifen—Headache—Everolimus—kidney cancer	3.41e-05	0.000355	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—kidney cancer	3.4e-05	0.000355	CcSEcCtD
Tamoxifen—Visual impairment—Capecitabine—kidney cancer	3.4e-05	0.000354	CcSEcCtD
Tamoxifen—Asthenia—Sorafenib—kidney cancer	3.39e-05	0.000353	CcSEcCtD
Tamoxifen—Leukopenia—Paclitaxel—kidney cancer	3.35e-05	0.000349	CcSEcCtD
Tamoxifen—Hypersensitivity—Sunitinib—kidney cancer	3.35e-05	0.000349	CcSEcCtD
Tamoxifen—Decreased appetite—Vincristine—kidney cancer	3.34e-05	0.000348	CcSEcCtD
Tamoxifen—Pruritus—Sorafenib—kidney cancer	3.34e-05	0.000348	CcSEcCtD
Tamoxifen—Vomiting—Erlotinib—kidney cancer	3.34e-05	0.000348	CcSEcCtD
Tamoxifen—Erythema multiforme—Capecitabine—kidney cancer	3.33e-05	0.000348	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Gemcitabine—kidney cancer	3.32e-05	0.000346	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vincristine—kidney cancer	3.32e-05	0.000346	CcSEcCtD
Tamoxifen—Fatigue—Vincristine—kidney cancer	3.31e-05	0.000345	CcSEcCtD
Tamoxifen—Rash—Erlotinib—kidney cancer	3.31e-05	0.000345	CcSEcCtD
Tamoxifen—Dermatitis—Erlotinib—kidney cancer	3.31e-05	0.000345	CcSEcCtD
Tamoxifen—Insomnia—Gemcitabine—kidney cancer	3.3e-05	0.000344	CcSEcCtD
Tamoxifen—Headache—Erlotinib—kidney cancer	3.29e-05	0.000343	CcSEcCtD
Tamoxifen—Constipation—Vincristine—kidney cancer	3.29e-05	0.000343	CcSEcCtD
Tamoxifen—Pain—Vincristine—kidney cancer	3.29e-05	0.000343	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—kidney cancer	3.29e-05	0.000343	CcSEcCtD
Tamoxifen—Paraesthesia—Gemcitabine—kidney cancer	3.27e-05	0.000341	CcSEcCtD
Tamoxifen—Flushing—Capecitabine—kidney cancer	3.27e-05	0.000341	CcSEcCtD
Tamoxifen—Cough—Paclitaxel—kidney cancer	3.26e-05	0.00034	CcSEcCtD
Tamoxifen—Asthenia—Sunitinib—kidney cancer	3.26e-05	0.00034	CcSEcCtD
Tamoxifen—Dyspnoea—Gemcitabine—kidney cancer	3.25e-05	0.000339	CcSEcCtD
Tamoxifen—Nausea—Vinblastine—kidney cancer	3.24e-05	0.000338	CcSEcCtD
Tamoxifen—Nausea—Everolimus—kidney cancer	3.23e-05	0.000337	CcSEcCtD
Tamoxifen—Diarrhoea—Sorafenib—kidney cancer	3.23e-05	0.000337	CcSEcCtD
Tamoxifen—Hypertension—Paclitaxel—kidney cancer	3.23e-05	0.000337	CcSEcCtD
Tamoxifen—Pruritus—Sunitinib—kidney cancer	3.22e-05	0.000335	CcSEcCtD
Tamoxifen—Arthralgia—Paclitaxel—kidney cancer	3.19e-05	0.000332	CcSEcCtD
Tamoxifen—Myalgia—Paclitaxel—kidney cancer	3.19e-05	0.000332	CcSEcCtD
Tamoxifen—Chest pain—Paclitaxel—kidney cancer	3.19e-05	0.000332	CcSEcCtD
Tamoxifen—Anxiety—Paclitaxel—kidney cancer	3.17e-05	0.000331	CcSEcCtD
Tamoxifen—Decreased appetite—Gemcitabine—kidney cancer	3.17e-05	0.00033	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—kidney cancer	3.17e-05	0.00033	CcSEcCtD
Tamoxifen—Arrhythmia—Capecitabine—kidney cancer	3.15e-05	0.000328	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Gemcitabine—kidney cancer	3.15e-05	0.000328	CcSEcCtD
Tamoxifen—Discomfort—Paclitaxel—kidney cancer	3.15e-05	0.000328	CcSEcCtD
Tamoxifen—Fatigue—Gemcitabine—kidney cancer	3.14e-05	0.000328	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vincristine—kidney cancer	3.14e-05	0.000328	CcSEcCtD
Tamoxifen—Dizziness—Sorafenib—kidney cancer	3.12e-05	0.000326	CcSEcCtD
Tamoxifen—Pain—Gemcitabine—kidney cancer	3.12e-05	0.000325	CcSEcCtD
Tamoxifen—Constipation—Gemcitabine—kidney cancer	3.12e-05	0.000325	CcSEcCtD
Tamoxifen—Nausea—Erlotinib—kidney cancer	3.12e-05	0.000325	CcSEcCtD
Tamoxifen—Alopecia—Capecitabine—kidney cancer	3.12e-05	0.000325	CcSEcCtD
Tamoxifen—Dry mouth—Paclitaxel—kidney cancer	3.11e-05	0.000325	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—kidney cancer	3.11e-05	0.000324	CcSEcCtD
Tamoxifen—Diarrhoea—Sunitinib—kidney cancer	3.11e-05	0.000324	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—kidney cancer	3.09e-05	0.000322	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—kidney cancer	3.08e-05	0.000321	CcSEcCtD
Tamoxifen—Erythema—Capecitabine—kidney cancer	3.07e-05	0.00032	CcSEcCtD
Tamoxifen—Oedema—Paclitaxel—kidney cancer	3.05e-05	0.000318	CcSEcCtD
Tamoxifen—Abdominal pain—Vincristine—kidney cancer	3.04e-05	0.000317	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—kidney cancer	3.03e-05	0.000316	CcSEcCtD
Tamoxifen—Infection—Paclitaxel—kidney cancer	3.03e-05	0.000316	CcSEcCtD
Tamoxifen—Dysgeusia—Capecitabine—kidney cancer	3.01e-05	0.000313	CcSEcCtD
Tamoxifen—Dizziness—Sunitinib—kidney cancer	3.01e-05	0.000313	CcSEcCtD
Tamoxifen—Vomiting—Sorafenib—kidney cancer	3e-05	0.000313	CcSEcCtD
Tamoxifen—Thrombocytopenia—Paclitaxel—kidney cancer	2.99e-05	0.000312	CcSEcCtD
Tamoxifen—Rash—Sorafenib—kidney cancer	2.98e-05	0.00031	CcSEcCtD
Tamoxifen—Dermatitis—Sorafenib—kidney cancer	2.98e-05	0.00031	CcSEcCtD
Tamoxifen—Back pain—Capecitabine—kidney cancer	2.97e-05	0.00031	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.96e-05	0.000308	CcSEcCtD
Tamoxifen—Headache—Sorafenib—kidney cancer	2.96e-05	0.000308	CcSEcCtD
Tamoxifen—Muscle spasms—Capecitabine—kidney cancer	2.95e-05	0.000308	CcSEcCtD
Tamoxifen—Hyperhidrosis—Paclitaxel—kidney cancer	2.95e-05	0.000308	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—kidney cancer	2.94e-05	0.000307	CcSEcCtD
Tamoxifen—Anorexia—Paclitaxel—kidney cancer	2.91e-05	0.000303	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.9e-05	0.000302	CcSEcCtD
Tamoxifen—Vomiting—Sunitinib—kidney cancer	2.89e-05	0.000301	CcSEcCtD
Tamoxifen—Rash—Sunitinib—kidney cancer	2.87e-05	0.000299	CcSEcCtD
Tamoxifen—Dermatitis—Sunitinib—kidney cancer	2.86e-05	0.000298	CcSEcCtD
Tamoxifen—Headache—Sunitinib—kidney cancer	2.85e-05	0.000297	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—kidney cancer	2.84e-05	0.000296	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—kidney cancer	2.84e-05	0.000296	CcSEcCtD
Tamoxifen—Anaemia—Capecitabine—kidney cancer	2.84e-05	0.000296	CcSEcCtD
Tamoxifen—Hypersensitivity—Vincristine—kidney cancer	2.83e-05	0.000295	CcSEcCtD
Tamoxifen—Nausea—Sorafenib—kidney cancer	2.81e-05	0.000292	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—kidney cancer	2.78e-05	0.00029	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.78e-05	0.00029	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—kidney cancer	2.77e-05	0.000288	CcSEcCtD
Tamoxifen—Insomnia—Paclitaxel—kidney cancer	2.76e-05	0.000288	CcSEcCtD
Tamoxifen—Asthenia—Vincristine—kidney cancer	2.76e-05	0.000287	CcSEcCtD
Tamoxifen—Leukopenia—Capecitabine—kidney cancer	2.75e-05	0.000286	CcSEcCtD
Tamoxifen—Paraesthesia—Paclitaxel—kidney cancer	2.74e-05	0.000286	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—kidney cancer	2.74e-05	0.000285	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—kidney cancer	2.73e-05	0.000285	CcSEcCtD
Tamoxifen—Dyspnoea—Paclitaxel—kidney cancer	2.72e-05	0.000284	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—kidney cancer	2.71e-05	0.000283	CcSEcCtD
Tamoxifen—Nausea—Sunitinib—kidney cancer	2.7e-05	0.000281	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—kidney cancer	2.7e-05	0.000281	CcSEcCtD
Tamoxifen—Dyspepsia—Paclitaxel—kidney cancer	2.69e-05	0.00028	CcSEcCtD
Tamoxifen—Cough—Capecitabine—kidney cancer	2.68e-05	0.000279	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—kidney cancer	2.66e-05	0.000277	CcSEcCtD
Tamoxifen—Decreased appetite—Paclitaxel—kidney cancer	2.65e-05	0.000277	CcSEcCtD
Tamoxifen—Hypertension—Capecitabine—kidney cancer	2.65e-05	0.000276	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.64e-05	0.000275	CcSEcCtD
Tamoxifen—Fatigue—Paclitaxel—kidney cancer	2.63e-05	0.000274	CcSEcCtD
Tamoxifen—Diarrhoea—Vincristine—kidney cancer	2.63e-05	0.000274	CcSEcCtD
Tamoxifen—Asthenia—Gemcitabine—kidney cancer	2.62e-05	0.000273	CcSEcCtD
Tamoxifen—Arthralgia—Capecitabine—kidney cancer	2.61e-05	0.000272	CcSEcCtD
Tamoxifen—Chest pain—Capecitabine—kidney cancer	2.61e-05	0.000272	CcSEcCtD
Tamoxifen—Myalgia—Capecitabine—kidney cancer	2.61e-05	0.000272	CcSEcCtD
Tamoxifen—Constipation—Paclitaxel—kidney cancer	2.61e-05	0.000272	CcSEcCtD
Tamoxifen—Pain—Paclitaxel—kidney cancer	2.61e-05	0.000272	CcSEcCtD
Tamoxifen—Anxiety—Capecitabine—kidney cancer	2.6e-05	0.000271	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—kidney cancer	2.58e-05	0.000269	CcSEcCtD
Tamoxifen—Discomfort—Capecitabine—kidney cancer	2.58e-05	0.000269	CcSEcCtD
Tamoxifen—Pruritus—Gemcitabine—kidney cancer	2.58e-05	0.000269	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—kidney cancer	2.57e-05	0.000268	CcSEcCtD
Tamoxifen—Dry mouth—Capecitabine—kidney cancer	2.56e-05	0.000266	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—kidney cancer	2.56e-05	0.000266	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—kidney cancer	2.55e-05	0.000265	CcSEcCtD
Tamoxifen—Dizziness—Vincristine—kidney cancer	2.54e-05	0.000265	CcSEcCtD
Tamoxifen—Methadone—ABCB1—kidney cancer	2.53e-05	0.021	CrCbGaD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.51e-05	0.000262	CcSEcCtD
Tamoxifen—Oedema—Capecitabine—kidney cancer	2.51e-05	0.000261	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Paclitaxel—kidney cancer	2.5e-05	0.00026	CcSEcCtD
Tamoxifen—Diarrhoea—Gemcitabine—kidney cancer	2.5e-05	0.00026	CcSEcCtD
Tamoxifen—Infection—Capecitabine—kidney cancer	2.49e-05	0.000259	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—kidney cancer	2.46e-05	0.000257	CcSEcCtD
Tamoxifen—Thrombocytopenia—Capecitabine—kidney cancer	2.45e-05	0.000256	CcSEcCtD
Tamoxifen—Vomiting—Vincristine—kidney cancer	2.44e-05	0.000255	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—kidney cancer	2.43e-05	0.000253	CcSEcCtD
Tamoxifen—Urticaria—Paclitaxel—kidney cancer	2.43e-05	0.000253	CcSEcCtD
Tamoxifen—Rash—Vincristine—kidney cancer	2.42e-05	0.000253	CcSEcCtD
Tamoxifen—Hyperhidrosis—Capecitabine—kidney cancer	2.42e-05	0.000252	CcSEcCtD
Tamoxifen—Dermatitis—Vincristine—kidney cancer	2.42e-05	0.000252	CcSEcCtD
Tamoxifen—Abdominal pain—Paclitaxel—kidney cancer	2.41e-05	0.000252	CcSEcCtD
Tamoxifen—Headache—Vincristine—kidney cancer	2.41e-05	0.000251	CcSEcCtD
Tamoxifen—Anorexia—Capecitabine—kidney cancer	2.39e-05	0.000249	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—kidney cancer	2.38e-05	0.000248	CcSEcCtD
Tamoxifen—Vomiting—Gemcitabine—kidney cancer	2.32e-05	0.000242	CcSEcCtD
Tamoxifen—Rash—Gemcitabine—kidney cancer	2.3e-05	0.00024	CcSEcCtD
Tamoxifen—Dermatitis—Gemcitabine—kidney cancer	2.3e-05	0.000239	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—kidney cancer	2.28e-05	0.000238	CcSEcCtD
Tamoxifen—Headache—Gemcitabine—kidney cancer	2.28e-05	0.000238	CcSEcCtD
Tamoxifen—Nausea—Vincristine—kidney cancer	2.28e-05	0.000238	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.28e-05	0.000238	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—kidney cancer	2.27e-05	0.000237	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—kidney cancer	2.27e-05	0.000237	CcSEcCtD
Tamoxifen—Insomnia—Capecitabine—kidney cancer	2.27e-05	0.000236	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—kidney cancer	2.26e-05	0.000236	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—kidney cancer	2.26e-05	0.000235	CcSEcCtD
Tamoxifen—Paraesthesia—Capecitabine—kidney cancer	2.25e-05	0.000235	CcSEcCtD
Tamoxifen—Hypersensitivity—Paclitaxel—kidney cancer	2.25e-05	0.000234	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—kidney cancer	2.24e-05	0.000233	CcSEcCtD
Tamoxifen—Dyspnoea—Capecitabine—kidney cancer	2.23e-05	0.000233	CcSEcCtD
Tamoxifen—Dyspepsia—Capecitabine—kidney cancer	2.21e-05	0.00023	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—kidney cancer	2.19e-05	0.000228	CcSEcCtD
Tamoxifen—Asthenia—Paclitaxel—kidney cancer	2.19e-05	0.000228	CcSEcCtD
Tamoxifen—Decreased appetite—Capecitabine—kidney cancer	2.18e-05	0.000227	CcSEcCtD
Tamoxifen—Nausea—Gemcitabine—kidney cancer	2.17e-05	0.000226	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Capecitabine—kidney cancer	2.16e-05	0.000225	CcSEcCtD
Tamoxifen—Fatigue—Capecitabine—kidney cancer	2.16e-05	0.000225	CcSEcCtD
Tamoxifen—Pruritus—Paclitaxel—kidney cancer	2.16e-05	0.000225	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—kidney cancer	2.15e-05	0.000224	CcSEcCtD
Tamoxifen—Constipation—Capecitabine—kidney cancer	2.14e-05	0.000223	CcSEcCtD
Tamoxifen—Pain—Capecitabine—kidney cancer	2.14e-05	0.000223	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—kidney cancer	2.11e-05	0.00022	CcSEcCtD
Tamoxifen—Diarrhoea—Paclitaxel—kidney cancer	2.09e-05	0.000218	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Capecitabine—kidney cancer	2.05e-05	0.000214	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—kidney cancer	2.03e-05	0.000212	CcSEcCtD
Tamoxifen—Dizziness—Paclitaxel—kidney cancer	2.02e-05	0.00021	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—kidney cancer	2.01e-05	0.000209	CcSEcCtD
Tamoxifen—Urticaria—Capecitabine—kidney cancer	1.99e-05	0.000207	CcSEcCtD
Tamoxifen—Abdominal pain—Capecitabine—kidney cancer	1.98e-05	0.000206	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—kidney cancer	1.98e-05	0.000206	CcSEcCtD
Tamoxifen—Vomiting—Paclitaxel—kidney cancer	1.94e-05	0.000202	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—kidney cancer	1.94e-05	0.000202	CcSEcCtD
Tamoxifen—Rash—Paclitaxel—kidney cancer	1.93e-05	0.000201	CcSEcCtD
Tamoxifen—Dermatitis—Paclitaxel—kidney cancer	1.92e-05	0.0002	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—kidney cancer	1.91e-05	0.0002	CcSEcCtD
Tamoxifen—Headache—Paclitaxel—kidney cancer	1.91e-05	0.000199	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—kidney cancer	1.9e-05	0.000198	CcSEcCtD
Tamoxifen—Hypersensitivity—Capecitabine—kidney cancer	1.85e-05	0.000192	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—kidney cancer	1.83e-05	0.000191	CcSEcCtD
Tamoxifen—Nausea—Paclitaxel—kidney cancer	1.81e-05	0.000189	CcSEcCtD
Tamoxifen—Asthenia—Capecitabine—kidney cancer	1.8e-05	0.000187	CcSEcCtD
Tamoxifen—Pruritus—Capecitabine—kidney cancer	1.77e-05	0.000185	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—kidney cancer	1.77e-05	0.000185	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—kidney cancer	1.73e-05	0.00018	CcSEcCtD
Tamoxifen—Diarrhoea—Capecitabine—kidney cancer	1.71e-05	0.000179	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—kidney cancer	1.71e-05	0.000178	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—kidney cancer	1.68e-05	0.000176	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—kidney cancer	1.68e-05	0.000176	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—kidney cancer	1.68e-05	0.000176	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—kidney cancer	1.68e-05	0.000175	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—kidney cancer	1.66e-05	0.000174	CcSEcCtD
Tamoxifen—Dizziness—Capecitabine—kidney cancer	1.66e-05	0.000173	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—kidney cancer	1.65e-05	0.000172	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—kidney cancer	1.62e-05	0.000168	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—kidney cancer	1.6e-05	0.000167	CcSEcCtD
Tamoxifen—Vomiting—Capecitabine—kidney cancer	1.59e-05	0.000166	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—kidney cancer	1.58e-05	0.000165	CcSEcCtD
Tamoxifen—Rash—Capecitabine—kidney cancer	1.58e-05	0.000165	CcSEcCtD
Tamoxifen—Dermatitis—Capecitabine—kidney cancer	1.58e-05	0.000165	CcSEcCtD
Tamoxifen—Headache—Capecitabine—kidney cancer	1.57e-05	0.000164	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—kidney cancer	1.56e-05	0.000163	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—kidney cancer	1.54e-05	0.00016	CcSEcCtD
Tamoxifen—Nausea—Capecitabine—kidney cancer	1.49e-05	0.000155	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.47e-05	0.000153	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—kidney cancer	1.46e-05	0.000152	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—kidney cancer	1.45e-05	0.000151	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—kidney cancer	1.44e-05	0.00015	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—kidney cancer	1.42e-05	0.000148	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—kidney cancer	1.4e-05	0.000146	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.39e-05	0.000145	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—kidney cancer	1.39e-05	0.000145	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—kidney cancer	1.38e-05	0.000144	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—kidney cancer	1.38e-05	0.000144	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—kidney cancer	1.32e-05	0.000138	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—kidney cancer	1.28e-05	0.000134	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—kidney cancer	1.28e-05	0.000133	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—kidney cancer	1.19e-05	0.000124	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—kidney cancer	1.16e-05	0.000121	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—kidney cancer	1.14e-05	0.000119	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—kidney cancer	1.11e-05	0.000115	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—kidney cancer	1.07e-05	0.000111	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—kidney cancer	1.03e-05	0.000107	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—kidney cancer	1.02e-05	0.000106	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—kidney cancer	1.02e-05	0.000106	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—kidney cancer	1.01e-05	0.000105	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—kidney cancer	9.59e-06	0.0001	CcSEcCtD
Tamoxifen—CYP2C8—Metabolism—GSTT1—kidney cancer	2.45e-06	5.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ACHE—kidney cancer	2.45e-06	5.14e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.44e-06	5.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.43e-06	5.1e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CA2—kidney cancer	2.41e-06	5.05e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.41e-06	5.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ITPR2—kidney cancer	2.4e-06	5.03e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP1A1—kidney cancer	2.38e-06	5e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CRABP1—kidney cancer	2.37e-06	4.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CA9—kidney cancer	2.36e-06	4.95e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.36e-06	4.95e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.36e-06	4.94e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ABCB1—kidney cancer	2.35e-06	4.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CRABP1—kidney cancer	2.35e-06	4.93e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.35e-06	4.93e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALAD—kidney cancer	2.35e-06	4.92e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ITPR2—kidney cancer	2.34e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—BCHE—kidney cancer	2.33e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SCARB1—kidney cancer	2.32e-06	4.86e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.31e-06	4.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC5A5—kidney cancer	2.3e-06	4.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS1—kidney cancer	2.3e-06	4.81e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.29e-06	4.8e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTM1—kidney cancer	2.28e-06	4.79e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF2—kidney cancer	2.28e-06	4.77e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN2B—kidney cancer	2.27e-06	4.75e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PSMD7—kidney cancer	2.25e-06	4.72e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.24e-06	4.69e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.24e-06	4.69e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC2A1—kidney cancer	2.22e-06	4.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.21e-06	4.63e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ITPR2—kidney cancer	2.21e-06	4.62e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1R—kidney cancer	2.2e-06	4.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTT1—kidney cancer	2.19e-06	4.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ACHE—kidney cancer	2.19e-06	4.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ITPR2—kidney cancer	2.19e-06	4.58e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.17e-06	4.54e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.15e-06	4.52e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.15e-06	4.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.15e-06	4.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PGK1—kidney cancer	2.15e-06	4.5e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—kidney cancer	2.14e-06	4.5e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PIK3CA—kidney cancer	2.14e-06	4.48e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTT1—kidney cancer	2.13e-06	4.47e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ACHE—kidney cancer	2.13e-06	4.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—BCHE—kidney cancer	2.13e-06	4.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.11e-06	4.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LDHB—kidney cancer	2.1e-06	4.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SCARB1—kidney cancer	2.07e-06	4.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS1—kidney cancer	2.05e-06	4.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.04e-06	4.27e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—POMC—kidney cancer	2.03e-06	4.25e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SCARB1—kidney cancer	2.02e-06	4.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.02e-06	4.23e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ACHE—kidney cancer	2.01e-06	4.22e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTT1—kidney cancer	2.01e-06	4.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CRABP1—kidney cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PSMD7—kidney cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTP1—kidney cancer	2.01e-06	4.2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS1—kidney cancer	2e-06	4.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTT1—kidney cancer	1.99e-06	4.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ACHE—kidney cancer	1.99e-06	4.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.98e-06	4.14e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTP1—kidney cancer	1.96e-06	4.12e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PSMD7—kidney cancer	1.96e-06	4.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTP1—kidney cancer	1.96e-06	4.11e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—POMC—kidney cancer	1.95e-06	4.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BCHE—kidney cancer	1.91e-06	3.99e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SCARB1—kidney cancer	1.9e-06	3.99e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ABCB1—kidney cancer	1.9e-06	3.98e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SCARB1—kidney cancer	1.89e-06	3.96e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS1—kidney cancer	1.88e-06	3.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.88e-06	3.94e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.88e-06	3.94e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTEN—kidney cancer	1.87e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ITPR2—kidney cancer	1.87e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS1—kidney cancer	1.87e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ABCB1—kidney cancer	1.86e-06	3.9e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—kidney cancer	1.86e-06	3.9e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ABCB1—kidney cancer	1.86e-06	3.89e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTP1—kidney cancer	1.85e-06	3.88e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PSMD7—kidney cancer	1.85e-06	3.87e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTM1—kidney cancer	1.84e-06	3.86e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC5A5—kidney cancer	1.84e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PSMD7—kidney cancer	1.83e-06	3.84e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CA9—kidney cancer	1.82e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.82e-06	3.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HIF1A—kidney cancer	1.81e-06	3.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TSC2—kidney cancer	1.81e-06	3.79e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTM1—kidney cancer	1.81e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTM1—kidney cancer	1.8e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CA—kidney cancer	1.79e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—POMC—kidney cancer	1.78e-06	3.73e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC2A1—kidney cancer	1.77e-06	3.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.76e-06	3.7e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—POMC—kidney cancer	1.76e-06	3.69e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ABCB1—kidney cancer	1.75e-06	3.68e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—kidney cancer	1.75e-06	3.67e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.75e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—kidney cancer	1.74e-06	3.64e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—kidney cancer	1.73e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.73e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.72e-06	3.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.72e-06	3.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.72e-06	3.6e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.71e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.71e-06	3.58e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTT1—kidney cancer	1.7e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ACHE—kidney cancer	1.7e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTM1—kidney cancer	1.7e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—kidney cancer	1.7e-06	3.56e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.69e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.67e-06	3.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.66e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—kidney cancer	1.62e-06	3.39e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—POMC—kidney cancer	1.61e-06	3.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SCARB1—kidney cancer	1.61e-06	3.38e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.61e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB1—kidney cancer	1.61e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS1—kidney cancer	1.6e-06	3.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—kidney cancer	1.6e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—kidney cancer	1.6e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PSMD7—kidney cancer	1.57e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTM1—kidney cancer	1.56e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—kidney cancer	1.56e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CRABP1—kidney cancer	1.55e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.54e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—POMC—kidney cancer	1.52e-06	3.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—kidney cancer	1.52e-06	3.18e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—kidney cancer	1.5e-06	3.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—kidney cancer	1.48e-06	3.11e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—kidney cancer	1.48e-06	3.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.48e-06	3.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.47e-06	3.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ITPR2—kidney cancer	1.44e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—kidney cancer	1.43e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—kidney cancer	1.42e-06	2.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.42e-06	2.97e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—kidney cancer	1.41e-06	2.96e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—kidney cancer	1.41e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.4e-06	2.94e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—kidney cancer	1.39e-06	2.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—kidney cancer	1.39e-06	2.92e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MAPK3—kidney cancer	1.39e-06	2.91e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—kidney cancer	1.38e-06	2.9e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.37e-06	2.88e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—kidney cancer	1.36e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—kidney cancer	1.36e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—kidney cancer	1.35e-06	2.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.33e-06	2.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.32e-06	2.77e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—kidney cancer	1.32e-06	2.77e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—kidney cancer	1.32e-06	2.77e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ACHE—kidney cancer	1.32e-06	2.76e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—kidney cancer	1.32e-06	2.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—kidney cancer	1.31e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—kidney cancer	1.3e-06	2.73e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—kidney cancer	1.29e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—kidney cancer	1.29e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—kidney cancer	1.28e-06	2.69e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—kidney cancer	1.28e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—kidney cancer	1.27e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—kidney cancer	1.27e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RAF1—kidney cancer	1.25e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RELA—kidney cancer	1.25e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SCARB1—kidney cancer	1.24e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—kidney cancer	1.24e-06	2.6e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—kidney cancer	1.24e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS1—kidney cancer	1.23e-06	2.58e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—kidney cancer	1.23e-06	2.57e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—kidney cancer	1.22e-06	2.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.22e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.21e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMD7—kidney cancer	1.21e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.2e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—kidney cancer	1.2e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—kidney cancer	1.18e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—kidney cancer	1.15e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—kidney cancer	1.15e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.13e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—kidney cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—kidney cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—kidney cancer	1.12e-06	2.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—kidney cancer	1.1e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—kidney cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—kidney cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—kidney cancer	1.09e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.08e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—kidney cancer	1.08e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—kidney cancer	1.06e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—kidney cancer	1.04e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.03e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—kidney cancer	1.02e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—kidney cancer	1.02e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—kidney cancer	9.96e-07	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.89e-07	2.07e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—kidney cancer	9.85e-07	2.06e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—kidney cancer	9.61e-07	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—kidney cancer	9.6e-07	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—kidney cancer	9.59e-07	2.01e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—kidney cancer	9.54e-07	2e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—kidney cancer	9.12e-07	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—kidney cancer	9.06e-07	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—kidney cancer	9.06e-07	1.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—kidney cancer	9.03e-07	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—kidney cancer	8.98e-07	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—kidney cancer	8.88e-07	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—kidney cancer	8.86e-07	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—kidney cancer	8.8e-07	1.84e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—kidney cancer	8.78e-07	1.84e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—kidney cancer	8.72e-07	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—kidney cancer	8.65e-07	1.81e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—kidney cancer	8.63e-07	1.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK1—kidney cancer	8.59e-07	1.8e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.45e-07	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—kidney cancer	8.38e-07	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—kidney cancer	8.37e-07	1.75e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—kidney cancer	8.11e-07	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.94e-07	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—kidney cancer	7.92e-07	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—kidney cancer	7.85e-07	1.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—kidney cancer	7.67e-07	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—kidney cancer	7.67e-07	1.61e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—kidney cancer	7.66e-07	1.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—kidney cancer	7.45e-07	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—kidney cancer	7.22e-07	1.51e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—kidney cancer	7.21e-07	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—kidney cancer	7.16e-07	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—kidney cancer	6.85e-07	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—kidney cancer	6.68e-07	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—kidney cancer	6.39e-07	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—kidney cancer	6.3e-07	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—kidney cancer	6.26e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—kidney cancer	6.25e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—kidney cancer	6.24e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—kidney cancer	6.12e-07	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—kidney cancer	5.92e-07	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—kidney cancer	5.9e-07	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—kidney cancer	5.41e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—kidney cancer	5.34e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—kidney cancer	4.83e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—kidney cancer	4.72e-07	9.9e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—kidney cancer	4.72e-07	9.88e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—kidney cancer	4.44e-07	9.31e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.41e-07	9.23e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—kidney cancer	4.12e-07	8.63e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.76e-07	7.89e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.91e-07	6.09e-06	CbGpPWpGaD
